Expanding aorto-iliac calcification quantification in kidney transplant recipients: prognostic implications for survival and renal function
- PMID: 40590968
- DOI: 10.1007/s00261-025-05090-9
Expanding aorto-iliac calcification quantification in kidney transplant recipients: prognostic implications for survival and renal function
Abstract
Background: Aorto-iliac calcification (AIC) is increasingly recognized as a prognostic marker in kidney transplantation, yet its relationship with long-term outcomes remains unclear.
Purpose: To evaluate whether pre-transplant AIC scores independently predict post-transplant mortality and renal function (eGFR trajectory) in kidney transplant recipients.
Methods: We retrospectively analyzed 150 renal transplant recipients ≥ 40 years old who underwent pre-transplant abdominopelvic CT within 3 years of surgery (2005-2018). AIC scores were calculated using a modified Agatston method. Primary outcome was all-cause mortality; secondary outcome was longitudinal eGFR. Cox proportional hazards models assessed the association between AIC and mortality. Linear mixed-effects models and nonparametric tests evaluated the relationship between AIC and eGFR trajectory. Time-dependent ROC curves evaluated model discrimination over time.
Results: Higher AIC scores were independently associated with increased mortality (adjusted HR per 100 units: 1.009, 95% CI: 1.004-1.013, p < 0.001). When modeled by quartiles, patients in the highest AIC quartile had a 10.87-fold higher adjusted mortality risk than those in the lowest (p < 0.001). AIC was not significantly associated with eGFR decline in either multivariable models or sensitivity analyses. Time-dependent AUCs ranged from 0.70 to 0.79 across 2-11 years, demonstrating stable model discrimination.
Conclusion: AIC is a robust predictor of post-transplant mortality but not of eGFR trajectory. Incorporating AIC quantification into pre-transplant evaluations may improve long-term risk stratification and guide clinical decision-making.
Keywords: Agatston score; Kidney transplantation; Mortality risk stratification; Survival prediction; Vascular calcification; eGFR trajectory.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interests: The authors declare no competing interests. Ethical approval: The Institutional Review Board (IRB) at our institution authorized this study. Consent to participate: Not applicable. Consent to publish: Not applicable.
Similar articles
-
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2. Cochrane Database Syst Rev. 2022. PMID: 36161421 Free PMC article.
-
Evaluation of the ventricular assist device programme in the UK.Health Technol Assess. 2006 Nov;10(48):1-119, iii-iv. doi: 10.3310/hta10480. Health Technol Assess. 2006. PMID: 17134596
-
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Feb 27;2(2):CD009966. doi: 10.1002/14651858.CD009966.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jul 30;8:CD009966. doi: 10.1002/14651858.CD009966.pub3. PMID: 28238223 Free PMC article. Updated.
-
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.Cochrane Database Syst Rev. 2017 Jul 20;7(7):CD004756. doi: 10.1002/14651858.CD004756.pub4. Cochrane Database Syst Rev. 2017. PMID: 28731207 Free PMC article.
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
References
6 References
-
- CDC. Chronic Kidney Disease. 2024 [cited 2025 Jan 12]. Chronic Kidney Disease in the United States, 2023. Available from: https://www.cdc.gov/kidney-disease/php/data-research/index.html
-
- USRDS [Internet]. [cited 2025 Jan 12]. Annual Data Report. Available from: https://usrds-adr.niddk.nih.gov/
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous